Mechanism of liver X receptor α and ATP binding cassette transporter A1 involved in preeclampsia using an optimized deep learning model
C.-C. Wu, D.-F. Gan, R. Cao, L.-C. Li Department of Obstetrics and Gynecology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China. llc123@fjmu.edu.cn
OBJECTIVE: Preeclampsia (PE) is a complex disease-causing multisystem damage. Many genes, environmental factors, and their interactions are involved in the development and progression of PE. The pathogenesis of PE is not fully understood, limiting the prevention and treatment of PE. The aim of this study was to investigate the effect of 4,4’-diisothiocyanato-stilbene-2,2’-disulfonic acid (DIDS), an ATP-binding cassette transporter A1 (ABCA1) blocker, on apoM mRNA and protein levels.
PATIENTS AND METHODS: The role of liver X receptor α (LXRα) and ABCA1 in the pathogenesis of PE was investigated by optimizing the design of DIDS inhibition based on a deep learning model.
RESULTS: The proportion of primipara in the research group, EOPE group, LOPE group, and controls was 59.82%, 65.85%, 56.34%, and 21.43%, respectively. The difference between the research group and the controls was statistically significant (p<0.01). In the clinical data, serum-free triiodothyronine (FT3), gestational age at delivery, high-density lipoprotein cholesterol (HDL-C), hemoglobin (HGB), albumin, and platelet (PLT) in the research group were lower than those in the controls (p<0.05).
CONCLUSIONS: ABCA1 is considered to affect apoM mRNA expression, G/HDL-C may increase the risk of LOPE, and overweight or obesity, abnormal glycemic regulation, and hypothyroidism are independent risk factors closely related to the pathogenesis of PE and its subgroups.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
C.-C. Wu, D.-F. Gan, R. Cao, L.-C. Li
Mechanism of liver X receptor α and ATP binding cassette transporter A1 involved in preeclampsia using an optimized deep learning model
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 13
Pages: 6319-6331
DOI: 10.26355/eurrev_202307_32992